And though the stroke data is considered interesting, there isnt clinical evidence that it boosts mental clarity or focus
Because booming consumer demand for GLP-1s was a primary reason for the shortages, it was a gold rush situation for compounders who made full use of regulatory gaps to build a large secondary market for their compounded GLP-1s by advertising the benefits without disclosing the risks
Wegovy might be a sensible first option if: You meet NICEs eligibility criteria and want a NICE-recommended option with several years of UK real-world data
In this Review, we summarize the current clinical evidence for GLP-1 receptor agonists and cancer risk, including thyroid, pancreatic, gastrointestinal, and hormone-dependent malignancies
One lost 100 pounds in six months. The challenge has been getting these drugs into the hands of people who can benefit from them and the high price tag one month of the drug can cost around $1,000, and getting it covered by insurance isnt a guarantee